Evidence-based care for suicidality as an ethical and professional imperative: How to decrease suicidal suffering and save lives.

Jobes, David A.; Barnett, Jeffrey E.

doi:10.1037/amp0001325

Cited by 3 publications

(4 citation statements)

References 72 publications

(106 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When comparing treatments and adoption of available EBPs for other leading causes of death, the apparent evidence-to-practice gap in suicide care is hard to understand or justify. Accordingly, Jobes and Barnett (in press) have argued that using evidence-based clinical care for suicidal risk has become an ethical and professional imperative within contemporary mental health care. Although notable challenges to such care exist, the good news is that treatment works, offering an opportunity to ameliorate the suffering of millions with serious suicidal thoughts and saving lives too often lost to suicide.…”

Section: Discussionmentioning

confidence: 99%

“…The clinical science of treating suicidality has evolved such that we now have several proven suicide-specific treatments with additional promising treatments in development (Jobes, 2023; Jobes & Barnett, in press). However, graduate programs, professional certification, and continuing education rarely focus on suicide-specific treatments as a competency for graduation or licensure.…”

Section: Clinician Trainingmentioning

confidence: 99%

“…The fear of litigation can drive “better safe than sorry” clinical practices that may not be in the patient’s best interest (Jobes, 2017). In truth, the best clinical risk management strategy is to use EBPs proven to effectively treat suicidality and to document that work well (Jobes & Barnett, in press).…”

Section: Clinician Trainingmentioning

confidence: 99%

See 2 more Smart Citations

Zero Suicide – What About “Treat”?

Grumet,

Jobes

2024

Crisis

Self Cite

View full text Add to dashboard Cite

In the United States annually there are 42,000 breast cancer deaths and 52,000 colorectal cancer deaths. Importantly, these leading killers have seen notable mortality declines over several decades largely due to robust screening, early detection, and use of proven clinical interventions (Caswell-Jin et al., 2024;Siegel et al., 2023). It is unimaginable that healthcare providers would disregard the use of evidence-based clinical practices for identifying and treating individuals for leading causes of death. To do otherwise would be utterly unacceptable within contemporary healthcare delivery. Yet evidence-based treatment approaches to suicidal thoughts and behaviors are routinely underutilized by providers.Suicide is a global issue, taking more than 700,000 lives annually (https://www.who.int/news-room/fact-sheets/ detail/suicide). Provisional data in the US for 2022 indicate that there were 49,449 suicides in the country-the highest suicide death count in recorded history (www.cdc. gov/nchs). Moreover, 2,553,000 American adults and teens reported attempting suicide that year and a whopping 16,600,000 Americans reported serious thoughts of suicide (Substance Abuse and Mental Health Services Administration, 2023). For individuals (and families) facing a suicide crisis, finding effective care can be fraught with challenges including timely access to care, insurance barriers, stigma, and the taboo to openly discuss it. While not all will access health-care providers for support or treatment, for those who do have the courage to ask for help, they should expect nothing less than compassion, clinical skill, and a reliance on proven treatments.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Clinician Trainingmentioning

confidence: 99%

See 1 more Smart Citation

Zero Suicide – What About “Treat”?

Grumet,

Jobes

2024

Crisis

Self Cite

View full text Add to dashboard Cite

show abstract

“…As discussed by Jobes ( 11 ), the advent of the “988 Suicide & Crisis Lifeline” in the United States is now creating an increasing awareness related to emotional crises and suicidal risk. As governments around the world endeavor to enhance crisis services with crisis lines and centers, there is increasing awareness that we must go beyond an acute crisis-only approach with a clear need to treat what causes suicidality ( 63 , 64 ).…”

Section: Discussionmentioning

confidence: 99%

The use of CAMS and DBT to effectively treat patients who are suicidal

Jobes,

Rizvi

2024

Front. Psychiatry

Self Cite

View full text Add to dashboard Cite

Around the world, suicide ideation, attempts, and deaths pose a major public and mental health challenge for patients (and their loved ones). Accordingly, there is a clear need for effective clinical treatments that reliably reduce suicidal thoughts and behaviors. In this article, we review the Collaborative Assessment and Management of Suicidality (CAMS) and Dialectical Behavior Therapy (DBT), two clinical treatments that rise to the highest levels of empirical rigor. Both CAMS and DBT are now supported by randomized controlled trials (RCTs), with independent replications, and meta-analyses. There are also supportive data related to training clinical providers to use CAMS and DBT with adherence. RCTs that investigate the use of both interventions within clinical trial research designs and the increasing use of these complementary approaches within routine clinical practice are discussed. Future directions for research and clinical use of CAMS and DBT are explored as means to effectively treat suicidal risk.

show abstract